Long-term Safety and Tolerability of AFFITOPE AD02

AD01 Follow up Extension Visit

NCT01225809 ·Status: COMPLETED

Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease

NCT01357629 ·Status: TERMINATED

Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease

NCT00633841 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability of AFFITOPE AD03

NCT01309763 ·Status: COMPLETED ·Phase: PHASE1

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

NCT00495417 ·Status: COMPLETED ·Phase: PHASE1

A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease

NCT05744401 ·Status: TERMINATED ·Phase: PHASE2

Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease

NCT00842816 ·Status: COMPLETED ·Phase: PHASE2

Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease

NCT01238991 ·Status: TERMINATED ·Phase: PHASE2

Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia

NCT00095719 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study

NCT00809510 ·Status: TERMINATED ·Phase: PHASE2

To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.

NCT00151502 ·Status: COMPLETED ·Phase: PHASE3

Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease

NCT05161715 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

NCT01549834 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease

NCT01009255 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia

NCT01327859 ·Status: COMPLETED ·Phase: PHASE3

A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease

NCT05328115 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD)

NCT03668405 ·Status: TERMINATED ·Phase: PHASE1

A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil

NCT01406145 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Tolerability Study of ABT-126 in Elderly

NCT00867399 ·Status: COMPLETED ·Phase: PHASE1

Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects

NCT06304883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

NCT02220738 ·Status: TERMINATED ·Phase: PHASE1

Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.

NCT00731224 ·Status: COMPLETED ·Phase: PHASE4

Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care

NCT03456349 ·Status: COMPLETED ·Phase: PHASE1

Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice

NCT02162264 ·Status: COMPLETED

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects

NCT00687141 ·Status: COMPLETED ·Phase: PHASE1